Hugo Peris

Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming.

Transcend Medical, Inc. operates as a medical device company. It develops medical devices for the treatment of glaucoma, the cause of adult irreversible blindness. The company was founded in 2005 and is headquartered in Lake Forest, CA.

ForSight VISION4, Inc. develops novel drug delivery therapies for treatment of retinal diseases. The company was founded on June 26, 009 and is headquartered in Menlo Park, CA.

ForSight VISION5, Inc. develops ocular drug delivery technologies and device solutions for ophthalmic diseases. It engages in the development of non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. Its lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to continually receive their medication. The company was founded by Eugene de Juan Jr., J. Andrew Corley and K. Angela Macfarlane in 2010 and is headquartered in Madison, NJ.

ForSight VISION6, Inc. provides health care services. The company is headquartered in Brisbane, CA.

Part of Alkermes Plc, Advanced Inhalation Research, Inc. is a company that develops dry-powder drug delivery systems for respiratory patients. The company is based in Cambridge, MA. The company was founded by Terrance G. McGuire, Justin S. Hanes. Advanced Inhalation Research was acquired by Alkermes, Inc., part of Alkermes Plc from September 16, 2011 on February 01, 1999 for $114.54 million.

Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI.

National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD.

The Medical Device Manufacturers Association operates as a trade association. The private company is based in Washington. The American company was founded by Thomas C. Thompson.

ForSight Labs LLC operates as an ophthalmic technology incubator. It focuses on developing and applying solutions to improve the sight, care, and quality of life of visually impaired patients. The company was founded by Eugene de Juan, Hanson S. Gifford and Henry A. Plain in 2005 and is headquartered in Menlo Park, CA.

Doheny Eye Institute is a private company that provides research and education programs related to eye care. The company is based in Los Angeles, CA. The CEO of the company is Marissa Goldberg.

Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY.

Fogarty Institute for Innovation is a non-profit company that believes innovation is the key to medical advancement. The company is based in Mountain View, CA. The company strives to shape the future of human health through their work. The company was founded by Thomas J. Fogarty. Andrew Cleeland has been the CEO of the company since 2017.

Ashvattha Therapeutics LLC provides healthcare services. The firm develops pharmaceutical products. The company is headquartered in Redwood City, CA.

Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh.

Theraly Fibrosis, Inc. operates as a commercial physical research company. The company was founded by Seulki Lee and is headquartered in Germantown, MD.

Alcon Vision LLC is a company that specializes in innovative eye care solutions. The company is based in Fort Worth, TX and was founded in 1945 by William Conner and Robert Alexander. The company offers both surgical and vision care solutions to their customers. Alcon is dedicated to transforming eye care possibilities into realities through the discovery and development of their innovative eye care products and solutions.

Vensana Capital Management LLC (Vensana Capital) is a venture capital and growth equity investment firm founded in 2019 by Peter Klein Justin & Kirk G. Nielsen. The firm is headquartered in Saint Paul, Minnesota.

Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York.

Voyant Biotherapeutics LLC develops ocular therapeutics to solve age-related macular degeneration. The private company is based in Menlo Park, CA.

Recognify Life Sciences, Inc. develops treatments for cognitive impairment associated with schizophrenia. The company is based in Brisbane, CA. The company was founded by Thomas C. Südhof, Matthew P. Pando, Kristen Angela MacFarlane, Gary Walker. Matthew P. Pando has been the CEO since incorporation.

LENZ Therapeutics, Inc. manufactures pharmaceuticals. The firm sells eye care products. The company was founded by James W. McCollum, Lee Nordan and Gerald Horn and is headquartered in Coronado, CA.

Perceive Biotherapeutics, Inc. is a biotech company that is focused on developing a diverse pipeline of targets and treatment modalities for various therapeutic verticals, with a particular emphasis on ophthalmology. The company is based in South San Francisco, CA. Perceive is backed by Deerfield Management and is planning to raise a series B later this year. The company was founded based on research that identified two novel protective biologies for treating retinal blindness, which were developed from collaborations in genetic science and target validation. Kristen Angela MacFarlane has been the CEO of the company since 2020.